A new study has revealed that a promising antioxidant drug could prevent sexual transmission of the Zika virus, offering a potential role for the drug in preventing spread among humans.
Browsing: Clinical > Infection control
Take a look at the top news stories of the week, including the FDA approval of HIV drug Biktarvy and the discovery of a genetic predisposition to congenital Zika syndrome.
In the era of meta-omics, infection control and prevention must consider healthcare-associated infections in the global context of pathobiome.
A recently published study has concluded that yaws eradication will require more than a single round of mass drug treatment – as per the current WHO strategy – as researchers confirm the appearance of antibiotic-resistant strains.
Oral vaccines are less immunogenic when given to infants in low-income countries, compared with high-income countries, limiting their potential public health impact and in this review the authors evaluate the factors that might contribute to this phenomenon.
The end of January saw the London Centre for Neglected Tropical Disease Research’s (LCNTDR; UK) annual anniversary event, this year commemorating the sixth anniversary of the London Declaration on Neglected Tropical Diseases (NTDs). Discover more about the research presented in this report.
Biothreats are in the limelight of the current military, scientific and medical debate. Although it is arguable whether they are a major impending risk, their political and societal relevance is out of discussion. They are one of the collective fears which characterize our epoch.
Infectious diseases remain a major cause of mortality across the globe, so if pathogens could therefore be harnessed as a weapon, the implications would certainly be severe and far-reaching. Find out more about biothreats and bioterrorism in our explainer.
Learn more about the top news stories of the week in our round-up, including the latest research on influenza, and new findings in MRSA infection.